Health Products Type I ? Class 1/Type I = High risk (serious health hazard). Class 2/Type II = Moderate risk. Class 3/Type III = Low risk. Updated 2023-06-22

JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling

See all recalls from JAMP →
Share: Facebook X / Twitter WhatsApp

Recalled Product

JAMP Venlafaxine XR 37.5 mg capsules


✅ What Should You Do?

  1. 🛑 Stop using this product immediately and set it aside.
  2. Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour).
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative? Search Amazon Canada for JAMP Venlafaxine XR 37.5 →

Hazard / Issue

Labelling

Issued by

Drugs and health products

⚠️ What You Should Do

Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
View official government recall